APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gout Medications

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gout Medications Industry Growth and Trends Forecast to 2032

Report ID 173996200128 December 2025111 pages

Choose your research edition.

Industry ResearchGout Medications Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Gout Medications Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Gout Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gout Medications Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Gout Medications Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Gout Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gout Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gout Medications is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gout Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gout Medications include AstraZeneca, FUJI YAKUHIN, Hikma Pharmaceuticals plc, lroko Pharmaceuticals, Merck, Novartis, Sanofi, Savient Pharmaceuticals, Inc. and Sebelalreland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gout Medications market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gout Medications market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gout Medications market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gout Medications.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gout Medications market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gout Medications Market by Company

AstraZeneca

FUJI YAKUHIN

Hikma Pharmaceuticals plc

lroko Pharmaceuticals

Merck

Novartis

Sanofi

Savient Pharmaceuticals, Inc.

Sebelalreland

Takeda Pharmaceutical Company Limited

Teijin Pharma

Astellas Pharma Hong Kong Co., Ltd

Haichuang Pharmaceutical

Hengrui Medicine

Tonghua Dongbao

ApicHope

INVENTISBIO CO. LTD.

Gout Medications Segment by Type

Gout Relief Drugs

Gout Treatment Drugs

Gout Medications Segment by Application

Primary Gout

Secondary Gout

Gout Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gout Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gout Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gout Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gout Medications manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gout Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gout Relief Drugs Table 2. Major Company of Gout Treatment Drugs Table 3. Global Gout Medications Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Gout Medications Sales by Type (2021-2026) & (K Units) Table 5. Global Gout Medications Sales Market Share in Volume by Type (2021-2026) Table 6. Global Gout Medications Sales by Type (2021-2026) & (US$ Million) Table 7. Global Gout Medications Sales Market Share in Value by Type (2021-2026) Table 8. Global Gout Medications Price by Type (2021-2026) & (US$/Unit) Table 9. Global Gout Medications Sales by Type (2027-2032) & (K Units) Table 10. Global Gout Medications Sales Market Share in Volume by Type (2027-2032) Table 11. Global Gout Medications Sales by Type (2027-2032) & (US$ Million) Table 12. Global Gout Medications Sales Market Share in Value by Type (2027-2032) Table 13. Global Gout Medications Price by Type (2027-2032) & (US$/Unit) Table 14. North America Gout Medications Sales by Type (2021-2026) & (K Units) Table 15. North America Gout Medications Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Gout Medications Sales by Type (2021-2026) & (K Units) Table 17. Europe Gout Medications Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Gout Medications Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Gout Medications Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Gout Medications Sales by Type (2021-2026) & (K Units) Table 21. Latin America Gout Medications Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Gout Medications Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Gout Medications Sales by Type (2021-2026) & (US$ Million) Table 24. Gout Medications Industry Trends Table 25. Gout Medications Industry Drivers Table 26. Gout Medications Industry Opportunities and Challenges Table 27. Gout Medications Industry Restraints Table 28. Global Gout Medications Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Gout Medications Revenue Market Share by Company (2021-2026) Table 30. Global Gout Medications Sales by Company (2021-2026) & (K Units) Table 31. Global Gout Medications Sales Share by Company (2021-2026) Table 32. Global Gout Medications Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Gout Medications Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Gout Medications Major Company Production Sites and Headquarters Table 35. Global Gout Medications Company, Product Type & Application Table 36. Global Gout Medications Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Gout Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Gout Medications Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Gout Medications Sales by Region (2021-2026) & (K Units) Table 41. Global Gout Medications Sales Market Share in Volume by Region (2021-2026) Table 42. Global Gout Medications Sales by Region (2021-2026) & (US$ Million) Table 43. Global Gout Medications Sales Market Share in Value by Region (2021-2026) Table 44. Global Gout Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Gout Medications Sales by Region (2027-2032) & (K Units) Table 46. Global Gout Medications Sales Market Share in Volume by Region (2027-2032) Table 47. Global Gout Medications Sales by Region (2027-2032) & (US$ Million) Table 48. Global Gout Medications Sales Market Share in Value by Region (2027-2032) Table 49. Global Gout Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Gout Medications Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Gout Medications Sales by Application (2021-2026) & (K Units) Table 52. Global Gout Medications Sales Market Share in Volume by Application (2021-2026) Table 53. Global Gout Medications Sales by Application (2021-2026) & (US$ Million) Table 54. Global Gout Medications Sales Market Share in Value by Application (2021-2026) Table 55. Global Gout Medications Price by Application (2021-2026) & (US$/Unit) Table 56. Global Gout Medications Sales by Application (2027-2032) & (K Units) Table 57. Global Gout Medications Sales Market Share in Volume by Application (2027-2032) Table 58. Global Gout Medications Sales by Application (2027-2032) & (US$ Million) Table 59. Global Gout Medications Sales Market Share in Value by Application (2027-2032) Table 60. Global Gout Medications Price by Application (2027-2032) & (US$/Unit) Table 61. North America Gout Medications Sales by Application (2021-2026) & (K Units) Table 62. North America Gout Medications Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Gout Medications Sales by Application (2021-2026) & (K Units) Table 64. Europe Gout Medications Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Gout Medications Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Gout Medications Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Gout Medications Sales by Application (2021-2026) & (K Units) Table 68. Latin America Gout Medications Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Gout Medications Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Gout Medications Sales by Application (2021-2026) & (US$ Million) Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AstraZeneca Gout Medications Product Portfolio Table 75. AstraZeneca Recent Development Table 76. FUJI YAKUHIN Company Information Table 77. FUJI YAKUHIN Business Overview Table 78. FUJI YAKUHIN Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. FUJI YAKUHIN Gout Medications Product Portfolio Table 80. FUJI YAKUHIN Recent Development Table 81. Hikma Pharmaceuticals plc Company Information Table 82. Hikma Pharmaceuticals plc Business Overview Table 83. Hikma Pharmaceuticals plc Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hikma Pharmaceuticals plc Gout Medications Product Portfolio Table 85. Hikma Pharmaceuticals plc Recent Development Table 86. lroko Pharmaceuticals Company Information Table 87. lroko Pharmaceuticals Business Overview Table 88. lroko Pharmaceuticals Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. lroko Pharmaceuticals Gout Medications Product Portfolio Table 90. lroko Pharmaceuticals Recent Development Table 91. Merck Company Information Table 92. Merck Business Overview Table 93. Merck Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Merck Gout Medications Product Portfolio Table 95. Merck Recent Development Table 96. Novartis Company Information Table 97. Novartis Business Overview Table 98. Novartis Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Novartis Gout Medications Product Portfolio Table 100. Novartis Recent Development Table 101. Sanofi Company Information Table 102. Sanofi Business Overview Table 103. Sanofi Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sanofi Gout Medications Product Portfolio Table 105. Sanofi Recent Development Table 106. Savient Pharmaceuticals, Inc. Company Information Table 107. Savient Pharmaceuticals, Inc. Business Overview Table 108. Savient Pharmaceuticals, Inc. Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Savient Pharmaceuticals, Inc. Gout Medications Product Portfolio Table 110. Savient Pharmaceuticals, Inc. Recent Development Table 111. Sebelalreland Company Information Table 112. Sebelalreland Business Overview Table 113. Sebelalreland Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Sebelalreland Gout Medications Product Portfolio Table 115. Sebelalreland Recent Development Table 116. Takeda Pharmaceutical Company Limited Company Information Table 117. Takeda Pharmaceutical Company Limited Business Overview Table 118. Takeda Pharmaceutical Company Limited Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Takeda Pharmaceutical Company Limited Gout Medications Product Portfolio Table 120. Takeda Pharmaceutical Company Limited Recent Development Table 121. Teijin Pharma Company Information Table 122. Teijin Pharma Business Overview Table 123. Teijin Pharma Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Teijin Pharma Gout Medications Product Portfolio Table 125. Teijin Pharma Recent Development Table 126. Astellas Pharma Hong Kong Co., Ltd Company Information Table 127. Astellas Pharma Hong Kong Co., Ltd Business Overview Table 128. Astellas Pharma Hong Kong Co., Ltd Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Astellas Pharma Hong Kong Co., Ltd Gout Medications Product Portfolio Table 130. Astellas Pharma Hong Kong Co., Ltd Recent Development Table 131. Haichuang Pharmaceutical Company Information Table 132. Haichuang Pharmaceutical Business Overview Table 133. Haichuang Pharmaceutical Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Haichuang Pharmaceutical Gout Medications Product Portfolio Table 135. Haichuang Pharmaceutical Recent Development Table 136. Hengrui Medicine Company Information Table 137. Hengrui Medicine Business Overview Table 138. Hengrui Medicine Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Hengrui Medicine Gout Medications Product Portfolio Table 140. Hengrui Medicine Recent Development Table 141. Tonghua Dongbao Company Information Table 142. Tonghua Dongbao Business Overview Table 143. Tonghua Dongbao Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Tonghua Dongbao Gout Medications Product Portfolio Table 145. Tonghua Dongbao Recent Development Table 146. ApicHope Company Information Table 147. ApicHope Business Overview Table 148. ApicHope Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. ApicHope Gout Medications Product Portfolio Table 150. ApicHope Recent Development Table 151. INVENTISBIO CO. LTD. Company Information Table 152. INVENTISBIO CO. LTD. Business Overview Table 153. INVENTISBIO CO. LTD. Gout Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. INVENTISBIO CO. LTD. Gout Medications Product Portfolio Table 155. INVENTISBIO CO. LTD. Recent Development Table 156. North America Gout Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. North America Gout Medications Sales by Country (2021-2026) & (K Units) Table 158. North America Gout Medications Sales Market Share by Country (2021-2026) Table 159. North America Gout Medications Sales Forecast by Country (2027-2032) & (K Units) Table 160. North America Gout Medications Sales Market Share Forecast by Country (2027-2032) Table 161. North America Gout Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Gout Medications Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Gout Medications Market Share by Country (2021-2026) Table 164. North America Gout Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Gout Medications Market Share Forecast by Country (2027-2032) Table 166. Europe Gout Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Europe Gout Medications Sales by Country (2021-2026) & (K Units) Table 168. Europe Gout Medications Sales Market Share by Country (2021-2026) Table 169. Europe Gout Medications Sales Forecast by Country (2027-2032) & (K Units) Table 170. Europe Gout Medications Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Gout Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Gout Medications Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Gout Medications Market Share by Country (2021-2026) Table 174. Europe Gout Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Gout Medications Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Gout Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Gout Medications Sales by Country (2021-2026) & (K Units) Table 178. Asia-Pacific Gout Medications Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Gout Medications Sales Forecast by Country (2027-2032) & (K Units) Table 180. Asia-Pacific Gout Medications Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Gout Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Gout Medications Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Gout Medications Market Share by Country (2021-2026) Table 184. Asia-Pacific Gout Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Gout Medications Market Share Forecast by Country (2027-2032) Table 186. Latin America Gout Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Latin America Gout Medications Sales by Country (2021-2026) & (K Units) Table 188. Latin America Gout Medications Sales Market Share by Country (2021-2026) Table 189. Latin America Gout Medications Sales Forecast by Country (2027-2032) & (K Units) Table 190. Latin America Gout Medications Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Gout Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Gout Medications Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Gout Medications Market Share by Country (2021-2026) Table 194. Latin America Gout Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Gout Medications Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Gout Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Gout Medications Sales by Country (2021-2026) & (K Units) Table 198. Middle East and Africa Gout Medications Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Gout Medications Sales Forecast by Country (2027-2032) & (K Units) Table 200. Middle East and Africa Gout Medications Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Gout Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Gout Medications Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Gout Medications Market Share by Country (2021-2026) Table 204. Middle East and Africa Gout Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Gout Medications Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Gout Medications Distributors List Table 209. Gout Medications Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Gout Medications Image Figure 2. Global Gout Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gout Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Gout Medications Sales (2021-2032) & (K Units) Figure 5. Gout Relief Drugs Image Figure 6. Global Gout Relief Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Gout Treatment Drugs Image Figure 8. Global Gout Treatment Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Gout Medications Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Gout Medications Market Share by Type 2025 VS 2032 Figure 11. North America Gout Medications Sales Market Share in Volume by Type in 2025 Figure 12. North America Gout Medications Sales Market Share in Value by Type in 2025 Figure 13. Europe Gout Medications Sales Market Share in Volume by Type in 2025 Figure 14. Europe Gout Medications Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Gout Medications Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Gout Medications Sales Market Share in Value by Type in 2025 Figure 17. Latin America Gout Medications Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Gout Medications Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Gout Medications Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Gout Medications Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Gout Medications Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Primary Gout Image Figure 24. Global Primary Gout Sales YoY Growth (2021-2032) & (K Units) Figure 25. Secondary Gout Image Figure 26. Global Secondary Gout Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Gout Medications Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Gout Medications Market Share by Application 2025 VS 2032 Figure 29. North America Gout Medications Sales Market Share in Volume by Application in 2025 Figure 30. North America Gout Medications Sales Market Share in Value by Application in 2025 Figure 31. Europe Gout Medications Sales Market Share in Volume by Application in 2025 Figure 32. Europe Gout Medications Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Gout Medications Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Gout Medications Sales Market Share in Value by Application in 2025 Figure 35. Latin America Gout Medications Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Gout Medications Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Gout Medications Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Gout Medications Sales Market Share in Value by Application in 2025 Figure 39. North America Gout Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Gout Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Gout Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Gout Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Gout Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Gout Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Gout Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Gout Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Gout Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Gout Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Gout Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Gout Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Gout Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Gout Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Gout Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Gout Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Gout Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Gout Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Gout Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Gout Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Gout Medications Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Gout Medications Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Gout Relief Drugs
  • Gout Treatment Drugs
Applications
  • Primary Gout
  • Secondary Gout
Companies covered
  • AstraZeneca
  • FUJI YAKUHIN
  • Hikma Pharmaceuticals plc
  • lroko Pharmaceuticals
  • Merck
  • Novartis
  • Sanofi
  • Savient Pharmaceuticals, Inc.
  • Sebelalreland
  • Takeda Pharmaceutical Company Limited
  • Teijin Pharma
  • Astellas Pharma Hong Kong Co., Ltd
  • Haichuang Pharmaceutical
  • Hengrui Medicine
  • Tonghua Dongbao
  • ApicHope
  • INVENTISBIO CO. LTD.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gout Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gout Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gout Medications Market by Type
  6. 1.3.1 Gout Relief Drugs
  7. 1.3.2 Gout Treatment Drugs
  8. 1.4 Global Gout Medications Market Size by Type
  9. 1.4.1 Global Gout Medications Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Gout Medications Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Gout Medications Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Gout Medications Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Gout Medications Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Gout Medications Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Gout Medications Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Gout Medications Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gout Medications Industry Trends
  2. 2.2 Gout Medications Industry Drivers
  3. 2.3 Gout Medications Industry Opportunities and Challenges
  4. 2.4 Gout Medications Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gout Medications Revenue (2021-2026)
  2. 3.2 Global Top Players by Gout Medications Sales (2021-2026)
  3. 3.3 Global Top Players by Gout Medications Price (2021-2026)
  4. 3.4 Global Gout Medications Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gout Medications Major Company Production Sites & Headquarters
  6. 3.6 Global Gout Medications Company, Product Type & Application
  7. 3.7 Global Gout Medications Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gout Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gout Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gout Medications Tier 1, Tier 2, and Tier 3
4 Gout Medications Regional Status and Outlook
  1. 4.1 Global Gout Medications Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gout Medications Historic Market Size by Region
  3. 4.2.1 Global Gout Medications Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gout Medications Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gout Medications Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gout Medications Forecasted Market Size by Region
  7. 4.3.1 Global Gout Medications Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gout Medications Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gout Medications Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gout Medications by Application
  1. 5.1 Gout Medications Market by Application
  2. 5.1.1 Primary Gout
  3. 5.1.2 Secondary Gout
  4. 5.2 Global Gout Medications Market Size by Application
  5. 5.2.1 Global Gout Medications Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Gout Medications Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Gout Medications Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Gout Medications Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Gout Medications Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Gout Medications Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Gout Medications Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Gout Medications Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Gout Medications Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 FUJI YAKUHIN
  8. 6.2.1 FUJI YAKUHIN Company Information
  9. 6.2.2 FUJI YAKUHIN Business Overview
  10. 6.2.3 FUJI YAKUHIN Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 FUJI YAKUHIN Gout Medications Product Portfolio
  12. 6.2.5 FUJI YAKUHIN Recent Developments
  13. 6.3 Hikma Pharmaceuticals plc
  14. 6.3.1 Hikma Pharmaceuticals plc Company Information
  15. 6.3.2 Hikma Pharmaceuticals plc Business Overview
  16. 6.3.3 Hikma Pharmaceuticals plc Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hikma Pharmaceuticals plc Gout Medications Product Portfolio
  18. 6.3.5 Hikma Pharmaceuticals plc Recent Developments
  19. 6.4 lroko Pharmaceuticals
  20. 6.4.1 lroko Pharmaceuticals Company Information
  21. 6.4.2 lroko Pharmaceuticals Business Overview
  22. 6.4.3 lroko Pharmaceuticals Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 lroko Pharmaceuticals Gout Medications Product Portfolio
  24. 6.4.5 lroko Pharmaceuticals Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Gout Medications Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Gout Medications Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Sanofi
  38. 6.7.1 Sanofi Company Information
  39. 6.7.2 Sanofi Business Overview
  40. 6.7.3 Sanofi Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi Gout Medications Product Portfolio
  42. 6.7.5 Sanofi Recent Developments
  43. 6.8 Savient Pharmaceuticals, Inc.
  44. 6.8.1 Savient Pharmaceuticals, Inc. Company Information
  45. 6.8.2 Savient Pharmaceuticals, Inc. Business Overview
  46. 6.8.3 Savient Pharmaceuticals, Inc. Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Savient Pharmaceuticals, Inc. Gout Medications Product Portfolio
  48. 6.8.5 Savient Pharmaceuticals, Inc. Recent Developments
  49. 6.9 Sebelalreland
  50. 6.9.1 Sebelalreland Company Information
  51. 6.9.2 Sebelalreland Business Overview
  52. 6.9.3 Sebelalreland Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sebelalreland Gout Medications Product Portfolio
  54. 6.9.5 Sebelalreland Recent Developments
  55. 6.10 Takeda Pharmaceutical Company Limited
  56. 6.10.1 Takeda Pharmaceutical Company Limited Company Information
  57. 6.10.2 Takeda Pharmaceutical Company Limited Business Overview
  58. 6.10.3 Takeda Pharmaceutical Company Limited Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Takeda Pharmaceutical Company Limited Gout Medications Product Portfolio
  60. 6.10.5 Takeda Pharmaceutical Company Limited Recent Developments
  61. 6.11 Teijin Pharma
  62. 6.11.1 Teijin Pharma Company Information
  63. 6.11.2 Teijin Pharma Business Overview
  64. 6.11.3 Teijin Pharma Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Teijin Pharma Gout Medications Product Portfolio
  66. 6.11.5 Teijin Pharma Recent Developments
  67. 6.12 Astellas Pharma Hong Kong Co., Ltd
  68. 6.12.1 Astellas Pharma Hong Kong Co., Ltd Company Information
  69. 6.12.2 Astellas Pharma Hong Kong Co., Ltd Business Overview
  70. 6.12.3 Astellas Pharma Hong Kong Co., Ltd Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Astellas Pharma Hong Kong Co., Ltd Gout Medications Product Portfolio
  72. 6.12.5 Astellas Pharma Hong Kong Co., Ltd Recent Developments
  73. 6.13 Haichuang Pharmaceutical
  74. 6.13.1 Haichuang Pharmaceutical Company Information
  75. 6.13.2 Haichuang Pharmaceutical Business Overview
  76. 6.13.3 Haichuang Pharmaceutical Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Haichuang Pharmaceutical Gout Medications Product Portfolio
  78. 6.13.5 Haichuang Pharmaceutical Recent Developments
  79. 6.14 Hengrui Medicine
  80. 6.14.1 Hengrui Medicine Company Information
  81. 6.14.2 Hengrui Medicine Business Overview
  82. 6.14.3 Hengrui Medicine Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hengrui Medicine Gout Medications Product Portfolio
  84. 6.14.5 Hengrui Medicine Recent Developments
  85. 6.15 Tonghua Dongbao
  86. 6.15.1 Tonghua Dongbao Company Information
  87. 6.15.2 Tonghua Dongbao Business Overview
  88. 6.15.3 Tonghua Dongbao Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Tonghua Dongbao Gout Medications Product Portfolio
  90. 6.15.5 Tonghua Dongbao Recent Developments
  91. 6.16 ApicHope
  92. 6.16.1 ApicHope Company Information
  93. 6.16.2 ApicHope Business Overview
  94. 6.16.3 ApicHope Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 ApicHope Gout Medications Product Portfolio
  96. 6.16.5 ApicHope Recent Developments
  97. 6.17 INVENTISBIO CO. LTD.
  98. 6.17.1 INVENTISBIO CO. LTD. Company Information
  99. 6.17.2 INVENTISBIO CO. LTD. Business Overview
  100. 6.17.3 INVENTISBIO CO. LTD. Gout Medications Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 INVENTISBIO CO. LTD. Gout Medications Product Portfolio
  102. 6.17.5 INVENTISBIO CO. LTD. Recent Developments
7 North America by Country
  1. 7.1 North America Gout Medications Sales by Country
  2. 7.1.1 North America Gout Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gout Medications Sales by Country (2021-2026)
  4. 7.1.3 North America Gout Medications Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gout Medications Market Size by Country
  6. 7.2.1 North America Gout Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gout Medications Market Size by Country (2021-2026)
  8. 7.2.3 North America Gout Medications Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gout Medications Sales by Country
  2. 8.1.1 Europe Gout Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gout Medications Sales by Country (2021-2026)
  4. 8.1.3 Europe Gout Medications Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gout Medications Market Size by Country
  6. 8.2.1 Europe Gout Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gout Medications Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gout Medications Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gout Medications Sales by Country
  2. 9.1.1 Asia-Pacific Gout Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gout Medications Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gout Medications Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gout Medications Market Size by Country
  6. 9.2.1 Asia-Pacific Gout Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gout Medications Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gout Medications Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gout Medications Sales by Country
  2. 10.1.1 South America Gout Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gout Medications Sales by Country (2021-2026)
  4. 10.1.3 South America Gout Medications Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gout Medications Market Size by Country
  6. 10.2.1 South America Gout Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gout Medications Market Size by Country (2021-2026)
  8. 10.2.3 South America Gout Medications Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gout Medications Sales by Country
  2. 11.1.1 Middle East and Africa Gout Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gout Medications Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gout Medications Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gout Medications Market Size by Country
  6. 11.2.1 Middle East and Africa Gout Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gout Medications Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gout Medications Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gout Medications Value Chain Analysis
  2. 12.1.1 Gout Medications Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gout Medications Production Mode & Process
  7. 12.2 Gout Medications Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gout Medications Distributors
  10. 12.2.3 Gout Medications Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst